Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Evalve gets $60mm through its Series D round

Executive Summary

Evalve (devices used in percutaneous repair of cardiac valves) has raised $60mm through the closing of its Series D venture round. BBT Fund led the financing and was joined by returning backers Delphi Ventures, New Enterprise Associates, Split Rock Partners, and Abbott Laboratories. The funds will go towards European marketing of MitraClip, which is used to treat regurgitation by repairing the patient's mitral valve, and for a pivotal study of the device in the US.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies